Journals / JAREM / 2021 / Cilt: 11 - Sayı: 3

The Clinico-radiologic Evaluation and Risk Factor of Ventilator-associated Pneumonia in a Pediatric Care Unit of a Tertiary Center

Üçüncü Basamak Bir Merkezin Pediatrik Yoğun Bakım Ünitesinde Ventilatörle İlişkili Pnömoninin Risk Faktörleri ve Klinik-radyolojik Değerlendirmesi

Journal
JAREM
Pages
262–268
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Clinical and radiologic evaluation of patients may be a clue for the estimation of the microbiology of VAP, which is highly recommended before the initiation of empirical antibiotherapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Ventilator-associated pneumonia (VAP) is the second most common form of hospital-acquired infection.
📊
Key Findings & Data:Methods: This was a retrospective observational study evaluating the clinico-radiologic characteristics of VAP in a pediatric intensive care unit (PICU) of a tertiary referral university hospital between January 2011 and December 2016.
💡
Conclusion & Impact:Conclusion: Clinical and radiologic evaluation of patients may be a clue for the estimation of the microbiology of VAP, which is highly recommended before the initiation of empirical antibiotherapy.
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Ventilator-associated pneumonia (VAP) is the second most common form of hospital-acquired infection. Prediction of possible etiologic agents and initiation of appropriate and narrow-spectrum antibiotherapy is crucial to reduce morbidity and mortality. Clinical and radiologic variable analyses may help clinicians to foresee the usual cause of VAP. Methods: This was a retrospective observational study evaluating the clinico-radiologic characteristics of VAP in a pediatric intensive care unit (PICU) of a tertiary referral university hospital between January 2011 and December 2016. Results: A total of 1,323 patients in the PICU were followed during the study period, wherein 78 with a median age of 10 months (1-188) were detected to have VAP. Patients were divided into two groups according to the etiologic agents as gram-positive (n=16, 20.5%) and gram-negative VAP (n=62, 79.5%). Radiologic findings included peribronchial thickening (n=32, 41.0%), diffuse interlobular septal thickening (n=38, 48.7%), patchy infiltrate (n=54, 69.2%), consolidation (n=54, 69.2%), and pleural effusion (n=21, 26.9%). The presence of consolidation and pleural effusion were significantly more common among the patients with gram-positive VAP (p-values are 0.004 and 0.02). Conclusion: Clinical and radiologic evaluation of patients may be a clue for the estimation of the microbiology of VAP, which is highly recommended before the initiation of empirical antibiotherapy.

Özet

Amaç: Ventilatör ilişkili pnömoni (VİP), hastane kaynaklı enfeksiyonun ikinci en yaygın şeklidir. Olası etiyolojik ajanın öngörülmesi ve uygun, dar spektrumlu antibiyotik tedavisinin başlatılması, morbidite ve mortaliteyi azaltmak için çok önemlidir. Klinik ve radyolojik değişkenlerin analizi, klinisyenlerin VİP’nin olağan şüphesini önceden görmelerine yardımcı olabilir. Yöntemler: Bu çalışma, Ocak 2011 ile Aralık 2016 arasında üçüncü basamak bir üniversite hastanesinin pediatrik yoğun bakım ünitesinde VİP’nin kliniko-radyolojik özelliklerini değerlendiren retrospektif bir gözlemsel çalışmaydı. Bulgular: Çalışma süresi boyunca çocuk yoğun bakım ünitesinde 1.323 hastayı takip ettik. Ortanca yaşı 10 ay olan (1-188) 78 hastada VİP tespit edildi. Hastalar etiyolojik etkenlere göre Gram-pozitif (n=16, %20,5) ve Gram-negatif ilişkili VİP (n=62, 79,5). Radyolojik bulgular arasında peribronşiyal kalınlaşma (n=32, %41,0) olmak üzere iki gruba ayrıldı. Diffüz interlobüler septal kalınlaşma (n=38, %48,7), yamalı infiltrat (n=54, %69,2), konsolidasyon (n=54, %69,2) ve plevral efüzyon (n=21, %26,9). Konsolidasyon varlığı ve plevral efüzyon, Gram-pozitif ventilatör ilişkili pnömonisi olan hastalarda anlamlı olarak daha yaygındı (p değerleri; 0,004 ve 0,02). Sonuç: Hastaların klinik, risk faktörleri ve laboratuvar parametreleriyle birlikte radyolojik olarak değerlendirilmesi VİP’nin olası etkeninin öngörülmesinde fayda sağlayarak, uygun etkene yönelik antibiyoterapinin kısa sürede başlanmasına olanak tanıyabilir.

🔖

Cite This Article

Somer, A., Gürler, N., Çalışkan, E., Atay, G., Demirkol, D. (2022). The Clinico-radiologic Evaluation and Risk Factor of Ventilator-associated Pneumonia in a Pediatric Care Unit of a Tertiary Center. JAREM, Cilt: 11 - Sayı: 3, 262–268. https://ajindex.com/articles/558154

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Kalil AC, Metersky ML, Klompas M, Muscedere M, Sweeney AD, Palmer LC et al. Management of adults with hospital-acquired and ventilator-associated pneumonia. 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016; 63: 61-50
  2. Gupta S, Boville BM, Blanton R, Lukasiewicz B, Wincek J, Bai C, et al. A multicentered prospective analysis of diagnosis, risk factors, and outcomes associated with pediatric ventilator-associated pneumonia. Pediatr Crit Care Med 2015; 16: 65-8
  3. Elward AM, Warren DK, Fraser VJ. Ventilator-associated pneumonia in pediatric intensive care unit patients: risk factors and outcomes. Pediatrics 2002; 109: 758-64
  4. Beardsley AL, Nitu ME, Cox EG, Benneyworth BD. An evaluation of various ventilator-associated infection criteria in a PICU. Pediatr Crit Care Med 2016; 17: 73-7
  5. Melsen WG, Rovers MM, Groenwold RH, Bergmans DC, Camus C, Bauer TT, et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis 2013; 13: 665-6
  6. Muscedere JG, Day A, Heyland DK. Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia. Clin Infect Dis 2010; 51(Suppl 1): S120-5
  7. Kollef MH, Hamilton CW, Ernst FR. Economic impact of ventilatorassociated pneumonia in a large matched cohort. Infect Control Hosp Epidemiol 2012; 33: 250-6
  8. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First-Twenty Fourth Informational Supplement. CLSI document M100-S21-S24. Wayne,PA: Clinical and Laboratory Standards Institute; 2011-2014
  9. Wayne P. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing: Twenty-fourth informational supplement. CLSI Document M100-S24 2014; 34: 100-24
  10. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care– associated infection and criteria for specific types of infections in the acute care setting Atlanta, Georgia. Am J Infect Control 2008; 36: 309-23
  11. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J, et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246: 697-25
  12. File TM. Epidemiology, pathogenesis, microbiology, and diagnosis of hospital-acquired and ventilator-associated pneumonia in adults. Avai